＊李麗玉醫師所有發表期刊論文 · 2015. 12. 23. · Long-term changes in trace elements in patients undergoing chronic hemodialysis. Biol Trace Elem Res. 2006;109(2):115-22

＊李麗玉醫師

所有發表期刊論文

1. Lee LY, Hsu HL, Chen HM, Hsueh C.＊ Ductal adenocarcinoma of the pancreas

with huge cystic degeneration: A lesion to be distinguished from pseudocyst

and mucinous cystadenocarcinoma. Int J Surg Pathol. 2003;11(3):235-9.

2. Wang AC, Lee LY, Lin CT, Chen JR.＊ A histologic and immunohistochemical

analysis of defective vaginal healing after continence taping procedures: a

prospective case-controlled pilot study. Am J Obstet Gynecol.

2004;191(6):1868-74.

3. Yang CH, Wu JYJ, Lee LY, Kuo MC, Lee SC, Yu KH.＊ Adult-onset Still’s disease

associated with hemophagocytic Syndrome: A case report and literature

review. Rheumatol. 2005;19(2):69-78.

4. Lee LY, Kang CJ, Hsieh YY, Hsueh S.＊ Diagnosis of nodal Langerhans cell

histiocytosis by fine needle aspiration cytology. Chang Gung Med J.

2005;28(10):735-9.

5. Chang KP, Lee LY, Yeh AR, Dai TS, Hao SP.＊ Endoscopic CO2 laser surgery for

an atypical carcinoid tumor of the epiglottis masquerading as a supraglottic

cyst. Head Neck. 2005;27(11):1004-7.

6. Wu CM, Lee YS, Wang TH, Lee LY, Kong WH, Chen ES, Wei ML, Liang Y, Hwang

TL.＊ Identification of differential gene expression between intestinal and

diffuse gastric cancer using a cDNA microarray. Oncol Rep.

2006;15(1):57-64.

7. Hsieh YY, Shen WS, Lee LY, Wu TL, Ning HC, Sun CF.＊ Long-term changes in

trace elements in patients undergoing chronic hemodialysis. Biol Trace

Elem Res. 2006;109(2):115-22.

8. HO KC, Yen TC, Ng SH, Chang JT, Lee LY, Liao CT, Kang CJ.＊ Negative Impact

of 18F-FDG PET for Restaging in a Case of Recurrent Buccal Cancer. Annals

of Nuclear Medicine and Science. 2006;19(2):115-8.

9. Liao CT, Chang JT, Wang HM, Ng SH, Hsueh C, Lee LY, Lin CH, Chen IH, Kang CJ,

Huang SF, Tsai MF, Yen TC.＊ Surgical outcome of T4a and resected T4b oral

cavity cancer.

10. Liao CT, Wang HM, Hsieh LL, Chang JT, Ng SH, Hsueh C, Lee LY, Lin CH, Chen IH,

Kang CJ, Huang SF, Yen TC.＊ Higher distant failure in young age tongue

cancer patients. Oral Oncol. 2006;42(7):718-25.

11. Liao CT, Wang HM, Ng SH, Yen TC, Lee LY, Hsueh C, Wei FC, Chen IH, Kang CJ,

Huang SF, Chang JT.＊ Good tumor control and survivals of squamous cell

carcinoma of buccal mucosa treated with radical surgery with or without

neck dissection in Taiwan. Oral Oncol. 2006;42(8):800-9.

12. Ng SH, Yen TC, Chang JT, Chan SC, Ko SF, Wang HM, Lee LY, Kang CJ, Wong AM,

Liao CT.＊ Prospective study of [18F]fluorodeoxyglucose positron emission

tomography and computed tomography and magnetic resonance imaging in

oral cavity squamous cell carcinoma with palpably negative neck. J Clin

Oncol. 2006;20;24(27):4371-6.

13. Kuo WL, Lee LY, Wu CM, Wang CC, Yu JS, Liang Y, Lo CH, Huang KH, Hwang TL.

＊ Differential expression of claudin-4 between intestinal and diffuse-type

gastric cancer. Oncol Rep. 2006;16(4):729-34.

14. Wu TJ, Lee LY, Yeh CN, Wu PY, Chao TC, Hwang TL, Jan TT, Chen MF.＊ Surgical

treatment and prognostic analysis for gastrointestinal stromal tumors (GISTs)

of the small intestine: Before the era of Imatinib Mesylate. BMC

Gastroenterol. 2006;6 (1):29:1-8.

15. Chen YJ, Chang JT, Lee LY, Wang HM, Liao CT, Chiu CC, Chen PJ, Cheng AJ.＊

DSG3 is overexpressed in head neck cancer and is a potential molecular target

for inhibition of oncogenesis. Oncogene. 2007;18;26:467-76.

16. Liao CT, Ng SH, Chang JT, Wang HM, Hsueh C, Lee LY, Tsao CK, Chen WH, Chen

IH, Kanh CJ, Huang SF, Yen TC.＊ T4b oral cavity cancer below the

mandibular notch is resectable with a favorable outcome. Oral Oncol.

2007;43(6):570-9.

17. Liao CT, Chang JT, Wang HM, Ng SH, Hsueh C, Lee LY, Lin CH, Chen IH, Huang

SF, Cheng AJ, Yen TC.＊ Survival in squamous cell carcinoma of the oral cavity:

differences between pT4 N0 and other stage IVA categories. Cancer.

2007;110(3):564-71.

18. Chang JT, Chan SH, Lin CY, Lin TY, Wang HM, Liao CT, Wang TH, Lee LY, Cheng

AJ.＊ Differentially expressed genes in radioresistant nasopharyngeal cancer

cells: gp96 and GDF15. Mol Cancer Ther. 2007;6(8):2271-9.

19. Liao CT, Kang CJ, Chang JT, Wang HM, Ng SH, Hsueh C, Lee LY, Lin CH, Cheng AJ,

Chen IH, Huang SF, Yen TC.＊ Survival of second and multiple primary

tumors in patients with oral cavity squamous cell carcinoma in the betel quid

chewing area. Oral Oncol. 2007;43(8):811-9.

20. Liao CT, Wang HM, Chang JT, Ng SH, Hsueh C, Lee LY, Lin CH, Chen IH, Huang

SF, Yen TC.＊ Analysis of risk factors for distant metastases in squamous cell

carcinoma of the oral cavity. Cancer. 2007;20;110(7):1501-8.


SF, Cheng AJ, Yen TC.＊ Salvage therapy in relapsed squamous cell carcinoma

of the oral cavity: How and when? Cancer. 2008;112(1):94-103.

22. Ngan KW, Jung SM, Lee LY, Chuang WY, Yeh CJ, Hsieh YY.＊

Immunohistochemical expression of OCT4 in primary central nervous system

germ cell tumours. J Clin Neurosci. 2008;15(2):149-52.


SF, Cheng AJ, Yen TC.＊ Analysis of risk factors of predictive local tumor

control in oral cavity cancer. Ann Surg Oncol. 2008;15(3):915-22.

24. Lin CY, Lee LY, Huang SF, Kang CJ, Fan KH, Wang HM, Chen EY, Chen IH, Liao

CT, Cheng AJ, Chang JT.＊ Treatment outcome of combined modalities for

buccal cancers: unilateral or bilateral neck radiation? Int J Radiat Oncol Biol

Phys. 2008;70(5):1373-81.

25. Lee LY, Wu CM, Wang CC, Yu JS, Liang Y, Huang KH, Lo CH, Hwang TL.＊

Expression of matrix metalloproteinases MMP-2 and MMP-9 in gastric cancer

and their relation to claudin-4 expression. Histol Histopathol.

2008;23(5):515-21.


SF, Cheng AJ, See LC, Yen TC.＊ Does adjuvant radiation therapy improve

outcomes in pT1-3N0 oral cavity cancer with tumor-free margins and

perineural invasion? Int J Radiat Oncol Biol Phys. 2008;71(2):371-6.

27. Liao CT, Huang SF, Chen IH, Chang JT, Wang HM, Ng SH, Hsueh C, Lee LY, Lin

CH, Cheng AJ, Yen TC.＊ When does skin excision allow the achievement of an

adequate local control rate in patients with squamous cell carcinoma

involving the buccal mucosa? Ann Surg Oncol. 2008;15(8):2187-94.

28. Chiu CC, Lin CY, Lee LY, Chen YJ, Kuo TF, Chang JT, Liao CT, Wang HM, Yen TC,

Shen CR, Liao SK, Cheng AJ.＊ Glucose-regulated protein 78 regulates

multiple malignant phenotypes in head and neck cancer and may serve as a

molecular target of therapeutic intervention. Mol Cancer Ther.

2008;7(9):2788-97.

29. Wu CC, Huang YS, Lee LY, Liang Y, Tang RP, Chang YS, Hsieh LL, Yu JS.＊

Overexpression and elevated plasma level of tumor-associated antigen

90K/Mac-2 binding protein in colorectal carcinoma. Proteomics Clin Appl.

2008;2(12):1586-95.

30. Liao CT, Huang SF, Chen IH, Chang JT, Wang HM, Ng SH, Hsueh C, Lee LY, Lin

CH, Cheng AJ, Yen TC.＊ Risk stratification of patients with oral cavity

squamous cell carcinoma and contralateral neck recurrence following radical

surgery. Ann Surg Oncol. 2009;16(1):159-70.


SF, Cheng AJ, See LC, Yen TC.＊ Pretreatment primary tumor suvmax

measured by FDG-PET and pathologic tumor depth predict for poor outcomes

in patients with oral cavity squamous cell carcinoma and pathologically

positive lymph nodes. Int J Radiat Oncol Biol Phys. 2009;73(3):764-71.

32. Chao A, Tsai CN, Hsueh S, Lee LY, Chen TC, Huang SL, Chao FY, Lai CH.＊ Does

Epstein-Barr Virus play a role in lymphoepithelioma-like carcinoma of the

uterine cervix? Int J Gynecol Pathol. 2009;28(3):279-85.


SF, Cheng AJ, Yen TC.＊ Preoperative [18F] Fluorodeoxyglucose positron

emission tomography standardized uptake value of neck lymph nodes

predicts neck cancer control and survival rates in patients with oral cavity

squamous cell carcinoma and pathologically positive lymph nodes. Int J

Radiat Oncol Biol Phys. 2009;74(4):1054-61.

34. Kuo TT＊, Chen TC, Lee LY, Lu PH. IgG4-positive plasma cells in cutaneous

Rosai-Dorfman disease: an additional immunohistochemical feature and

possible relationship to IgG4-related sclerosing disease. J Cutan Pathol.

2009;36(10):1069-73.

35. Kang CJ, Chen YJ, Liao CT, Wang HM, Chang JT, Lin CY, Lee LY, Wang TH, Yen TC,

Shen CR, Chen IH, Chiu CC, Cheng AJ.＊ Transcriptome profiling and network

pathway analysis of genes associated with invasive phenotype in oral cancer.

Cancer Lett. 2009;284(2):131-40.

36. Liao CT, Chang JT, Wang HM, Ng SH, Huang SF, Chen IH, Hsueh C, Lee LY, Lin

CH, Cheng AJ, Yen TC.＊ Preoperative [(18)F]-fluorodeoxyglucose positron

emission tomography standardized uptake value of neck lymph nodes may

aid in selecting patients with oral cavity squamous cell carcinoma for salvage

therapy after relapse. Eur J Nucl Med Mol Imaging. 2009;36(11):1783-93.

37. Fang KH, Kao HK, Cheng MH, Chang YL, Tsang NM, Huang YC, Lee LY, Yu JS,

Hao SP, Chang KP.＊ Histological differentiation of primary oral squamous

cell carcinomas in an area of betel quid chewing prevalence. Otolaryngol

Head Neck Surg. 2009;141(6):743-9.

38. Kuo TT＊, Chen TC, Lee LY. Sclerosing angiomatoid nodular transformation of

the spleen (SANT): clinicopathological study of 10 cases with or without

abdominal disseminated calcifying fibrous tumors, and the presence of a

significant number of IgG4+ plasma cells. Pathol Int. 2009;59(12):844-50.

39. Tam YY, Lee LY, Chang KP.＊ Lymphoepithelial Carcinoma of the Nasolacrimal

Duct. Otolaryngol Head Neck Surg. 2010;142(1):144-5.

40. Chen HH, Lee LY, Chin SC, Chen IH, Liao CT, Huang SF.＊ Carcinoma ex

pleomorphic adenoma of soft palate with cavernous sinus invasion. World J

Surg Oncol. 2010;8(1):24.

41. Liao CT, Huang SF, Chen IH, Kang CJ, Lin CY, Fan KH, Wang HM, Ng SH, Hsueh C,

Lee LY, Tsao CK, Yen TC.＊ Outcome analysis of patients with pN2 oral cavity

cancer. Ann Surg Oncol. 2010;17(4):1118-26.

42. Chou CF, Chin SC, Lee LY, Chen IH, Liao CT, Huang SF.＊ A nasal cavity

mucosal melanoma connected by nasolacrimal duct in a patient with multiple

co-morbidities: a treatment dilemma. World J Oncol. 2010;1:182-5.

43. Liao CT, Wang HM, Chang JT, Lin CY, Ng SH, Huang SF, Chen IH, Hsueh C, Lee LY,

Lin CH, Cheng AJ, Yen TC.＊ Influence of pathological nodal status and

maximal standardized uptake value of the primary tumor and regional lymph

nodes on treatment plans in patients with advanced oral cavity squamous cell

carcinoma. Int J Radiat Oncol Biol Phys. 2010;77(2):421-9

44. .Ueng SH, Pinto M, Alvarado-Cabrero I, Lee LY, Tavassoli F.＊ Ovarian

malignant melanoma: a clinicopathologic study of 5 cases. Int J Surg Pathol.

2010;18(3):184-92.

45. Fang KH, Wang HM, Kang CJ, Lee LY, Huang SF, Lin CY, Chen EY, Chen IH, Liao

CT, Chang JT.＊ Treatment results of postoperative radiotherapy on

squamous cell carcinoma of the oral cavity: coexistence of multiple minor risk

factors results in higher recurrence rates. Int J Radiat Oncol Biol Phys.

2010;77(4):1024-9.

46. Chang KP, Wu CC, Chen HC, Chen SJ, Peng PH, Tsang NM, Lee LY, Liu SC, Liang Y,

Lee YS, Hao SP, Chang YS, Yu JS.＊ Identification of candidate nasopharyngeal

carcinoma serum biomarkers by cancer cell secretome and tissue

transcriptome analysis: potential usage of cystatin for predicting nodal stage

and poor prognosis. Proteomics. 2010;10(14):2644-60.

47. Lin CY, Chen WH, Liao CT, Chen IH, Chiu CC, Wang HM, Yen TC, Lee LY, Chang

JT, Cheng AJ.＊ Positive association of glucose-regulated protein 78 during

oral cancer progression and the prognostic value in oral precancerous lesion.

Head Neck. 2010;32(8):1028-39.

48. Hwang TL, Lee LY, Wang CC, Liang Y, Huang SF, Wu CM.＊ Claudin-4

expression is associated with tumor invasion, MMP-2 and MMP-9 expression

in gastric cancer. Exp Ther Med. 2010;1(5):789-97.

49. Huang SF, Chuang WY, Cheng SD, Hsin LJ, Lee LY, Kao HK.＊ A colliding

maxillary sinus cancer of adenosquamous carcinoma and small cell

neuroendocrine carcinoma - a case report with EGFR copy number analysis.

World J Surg Oncol. 2010;8(1):92.

50. Liao CT, Huang SF, Chen IH, Kang CJ, Lin CY, Fan KH, Wang HM, Ng SH, Hsueh C,

Lee LY, Lin CH, Yen TC.＊ Tongue and buccal mucosa carcinoma: is there a

difference in outcome? Ann Surg Oncol. 2010;17(11):2984-91.

51. Lin CY, Wang HM, Kang CJ, Lee LY, Huang SF, Fan KH, Chen EY, Chen IH, Liao CT,

Chang JT.＊ Primary tumor site as a predictor of treatment outcome for

definitive radiotherapy of advanced-stage oral cavity cancers. Int J Radiat

Oncol Biol Phys. 2010;78(4):1011-9.

52. Chen YJ, Liao CT, Chen PJ, Lee LY, Li YC, Chen IH, Wang HM, Chang JT, Chen LJ,

Yen TC, Tang CY, Cheng AJ.＊ Downregulation of Ches 1 and other novel

genes in oral cancer cells chronically exposed to areca nut extract. Head

Neck. 2011;33(2):257-66.

53. Liao CT, Wang HM＊, Huang SF, Chen IH, Kang CJ, Lin CY, Fan KH, Ng SH,

Hsueh C, Lee LY, Lin CH, Yen TC.＊ PET and PET/CT of the neck lymph nodes

improves risk prediction in patients with squamous cell carcinoma of the oral

cavity. J Nucl Med. 2011;52(2):180-7.

54. Chang KP, Kao HK, Yen TC, Chang YL, Liang Y, Liu SC, Lee LY, Chang YL, Kang CJ,

Chen IH, Liao CT, Yu JS.＊ Overexpression of macrophage inflammatory

protein-3αin oral squamous cell carcinoma is associated with nodal

metastasis. Oral Oncol. 2011;47(2):108-13.

55. Abd El-Hafez YG, Chen CC, Ng SH, Lin CY, Wang HM, Chan SC, Chen IH, Huan SF,

Kang CJ, Lee LY, Lin CH, Liao CT, Yen TC.＊ Comparison of PET/CT and MRI

for the detection of bone marrow invasion in patients with squamous cell

carcinoma of the oral cavity. Oral Oncol. 2011;47(4):288-95.

56. Lee LY, Chang KP, Hsu CL, Chen TC, Kuo TT.＊ Small cell neuroendocrine

carcinoma of the nasopharynx: report of a rare case lacking association with

Epstein - Barr virus. Int J Surg Pathol. 2011;19 (2):199-202.

57. Chen HH, Chen IH, Liao CT, Wei FC, Lee LY, Huang SF.＊ Preoperative

circulating C - reactive protein levels predict pathological aggressiveness in

oral squamous cell carcinoma. Clin Otolaryngol. 2011;36(2):147-53.

58. Lee LY, Chen TC, Kuo TT.＊ Simultaneous occurrence of IgG4-related chronic

sclerosing dacryoadenitis and chronic sclerosing sialadenitis associated with

lymph node involvement and Warthin's tumor. Int J Surg Pathol. 2011;19

(3):369-72.

59. Chiu CC, Lin CY, Lee LY, Chen YJ, Lu YC, Wang HM, Liao CT, Chang JT, Cheng AJ.

＊ Molecular chaperones as a common set of proteins that regulate the

invasion phenotype of head and neck cancer. Clin Cancer Res.

2011;17(14):4629-41.

60. Chen TD, Lee LY.＊ Rosai-Dorfman disease presenting in the parotid gland

with features of IgG4-related sclerosing disease. Arch

Otolaryngol Head Neck Surg. 2011;137(7)705-8. (corresponding author)

61. Liao CT, Lin CY, Fan KH, Huang SF, Chen IH, Kang CJ, Wang HM, Ng SH, Hsueh C,

Lee LY, Lin CH, Yen TC.＊ Identification of a high-risk subgroup of patients

with resected pT3 oral cavity cancer in need of postoperative adjuvant

therapy. Ann Surg Oncol. 2011;18(9):2569-78.

62. Lin CY, Lin TY, Wang HM, Huang SF, Fan KH, Liao CT, Chen IH, Lee LY, Li YL,

Chen YJ, Cheng AJ, Chang JT.＊ GP96 is over-expressed in oral cavity cancer

and is a poor prognostic indicator for patients receiving radiotherapy.

Radiat Oncol. 2011;6(1):136.

63. Liao CT, Lee LY, Huang SF, Chen IH, Kang CJ, Lin CY, Fan KH, Wang HM, Ng SH,

Yen TC.＊ Outcome analysis of patients with oral cavity cancer and

extracapsular spread in neck lymph nodes. Int J Radiat Oncol Biol Phys.

2011;81(4):930-7.

64. Kang CJ, Lin CY, Wang HM, Fan KH, Ng SH, Lee LY, Chen IH, Huang SF, Liao CT,

Yen TC.＊ The number of pathologically positive lymph nodes and

pathological tumor depth predicts prognosis in patients with poorly

differentiated squamous cell carcinoma of the oral cavity. Int J Radiat Oncol

Biol Phys. 2011;81(4):e223-30.

65. Kang CJ, Liao CT, Hsueh C, Lee LY, Lin CY, Fan KH, Wang HM, Huang SF, Chen IH,

Ng SH, Tsao CK, Huang YC, Yen TC.＊ Outcome analysis of patients with

well-differentiated oral cavity squamous cell carcinoma. Oral Oncol.

2011;47(11):1085-91.

66. Chang KP, Yu JS, Chien KY, Lee CW, Liang Y, Liao CT, Yen TC, Lee LY, Huang LL,

Liu SC, Chang YS, Chi LM.＊ Identification of PRDX4 and P4HA2 as

metastasis-associated proteins in oral cavity squamous cell carcinoma by

comparative tissue proteomics of microdissected specimens using iTRAQ

technology. J Proteome Res. 2011;10(11):4935-47.

67. Chen TD, Chuang HC, Lee LY.＊ Adenoid basal carcinoma of the uterine cervix:

clinicopathologic features of twelve cases with reference to CD117 expression.

Int. J. Gynecol. Pathol. 2012;31(1):25-32. (corresponding author)

68. Liao CT, Lin CY, Fan KH, Wang HM, Ng SH, Lee LY, Hsueh C, Chen IH, Huang SF,

Kang CJ, Yen TC.＊ Identification of a high-risk group among patients with

oral cavity squamous cell carcinoma and pT1-2N0 disease. Int J Radiat

Oncol Biol Phys. 2012 ;82(1):284-90.

69. Hsu HH, Lee LY,＊ Chang KP. Pathology quiz case 2. Arch Otolaryngol Head

Neck Surg. 2012;138(1):97. (corresponding author)

70. Hwang TL, Lee LY, Wang CC, Liang Y, Huang SF, Wu CM.＊ CCL7 and CCL21

overexpression in gastric cancer is associated with lymph node metastasis

and poor prognosis. World J Gastroenterol. 2012;18(11): 1249-1256.

71. Shen SC, Liao CH, Lo YF, Tsai HP, Kuo WL, Yu CC, Chao TC, Chen MF, Chang HK,

Lin YC, Shen WC, Ueng SH, Lee LY, Hsueh S, Huang YT, Chen SC.＊ Favorable

outcome of secondary axillary dissection in breast cancer patients with

axillary nodal relapse. Ann Surg Oncol. 2012;19(4):1122-8.

72. Liao CT, Hsueh C, Lee LY, Lin CY, Fan KH, Wang HM, Huang SF, Chen IH, Kang CJ,

Ng SH, Tsao CK, Huang YC, Yen TC.＊ Neck dissection field and lymph node

density predict prognosis in patients with oral cavity cancer and pathological

node metastases treated with adjuvant therapy. Oral Oncol.

2012;48(4):329-36. (co-first author)

73. Liao CT, Fan KH, Lin CY, Wang HM, Huang SF, Chen IH, Kang CJ, Ng SH, Hsueh C,

Lee LY, Lin CH, Yen TC.＊ Impact of a second FDG PET scan before adjuvant

therapy for the early detection of residual/relapsing tumours in high-risk

patients with oral cavity cancer and pathological extracapsular spread. Eur J

Nucl Med Mol Imaging. 2012;39(6):944-55.

74. Lee LA, Huang CG, Liao CT, Lee LY, Hsueh C, Chen TC, Lin CY, Fan KH, Wang HM,

Huang SF, Chen IH, Kang CJ, Ng SH, Yang SL, Tsao KC, Chang YL, Yen TC.＊

Human papillomavirus-16 infection in advanced oral cavity cancer patients is

related to an increased risk of distant metastases and poor survival. PLoS

One. 2012;7(7):e40767.

75. Hsu CL, Chang KP, Lin CY, Chang HK, Wang CH, Lin TL, Liao CT, Tsang NM, Lee

LY, Chan SC, Ng SH, Li HP, Chang YS, Wang HM.＊Plasma Epstein-Barr virus

DNA concentration and clearance rate as novel prognostic factors for

metastatic nasopharyngeal carcinoma. Head Neck. 2012;34(8):1064-70.

76. Tsan DL, Lin CY, Kang CJ, Huang SF, Fan KH, Liao CT, Chen IH, Lee LY, Wang HM,

Chang JT.＊ The comparison between weekly and three-weekly cisplatin

delivered concurrently with radiotherapy for patients with postoperative

high-risk squamous cell carcinoma of the oral cavity. Radiat Oncol.

2012;7(1):215.

77. Liao CT, Lin CY, Fan KH, Hsueh C, Lee LY, Wang HM, Huang SF, Chen IH, Kang CJ,

Ng SH, Lin CH, Huang YC, Yen TC.＊ Outcome analyses of unusual site neck

recurrence in oral cavity cancer. Ann Surg Oncol. 2013;20(1):257-66.

78. Lee LY, Kuo TT.＊ Hyaline globules in a nasopharyngeal carcinoma. Int J

Surg Pathol. 2013;21(1):44.

79. Liao CT, Lee LY, Hsueh C, Lin CY, Fan KH, Wang HM, Ng SH, Lin CH, Tsao CK,

Chen IH, Chang KP, Huang SF, Kang CJ, Fang KH, Wang YC, Chang YL, Huang YC,

Tsai CY, Yen TC.＊ Comparative outcomes in oral cavity cancer with resected

pT4a and pT4b. Oral Oncol. 2013;49(3):230-6.

80. Chen YJ, Lee LY, Chao YK, Chang JT, Lu YC, Li HF, Chiu CC, Li YC, Li YL, Chiou JF,

Cheng AJ.＊ DSG3 Facilitates Cancer Cell Growth and Invasion through the

DSG3-Plakoglobin-TCF/LEF-Myc/Cyclin D1/MMP Signaling Pathway. PLoS

One. 2013;8(5):e64088.

81. Hsu CL, Chan SC, Chang KP, Lin TL, Lin CY, Hsieh CH, Huang SF, Tsang NM, Lee

LY, Ng SH, Wang HM.＊ Clinical scenario of EBV DNA follow-up in patients of

treated localized nasopharyngeal carcinoma. Oral Oncol. 2013;49(6):620-5.

82. Kao PH, Lee LY, Wu YF, Yang CH, Kuo TT.＊ A rapidly recurring cutaneous

xanthogranuloma-like histiocytic tumor: a diagnostic challenge. Am J

Dermatopathol. 2013;35(4):e60-2.

83. Chao A, Lee LY, Hsueh C, Lin CY, Tsai CL, Chao AS, Lin CT, Chou HH, Chang TC ,

Wang TH.＊ Immunohistological analysis of stress-induced phosphoprotein

1 in ovarian cancer patients with low serum cancer antigen 125 levels.

Taiwan. J. Obstet. Gynecol. 2013;52(2) 185-191.

84. Lee LA, Huang CG, Tsao KC, Liao CT, Kang CJ, Chang KP, Huang SF, Chen IH,

Fang TJ, Li HY, Yang SL, Lee LY, Hsueh C, Chen TC, Lin CY, Fan KH, Wang HM,

Ng SH, Chang YL, Lai CH, Shih SR, Yen TC.＊ Increasing rates of low-risk

human papillomavirus infections in patients with oral cavity squamous cell

carcinoma: Association with clinical outcomes. J Clin Virol.

2013;57(4):331-7.

85. Chen TD, Lee LY.＊ Tumor-to-tumor metastasis: a case of renal cell

carcinoma metastatic to invasive ductal carcinoma of the breast. J Formos

Med Assoc. (corresponding author) (in press)

86. 總校閱李麗玉, 原著：Mitchell, Kumar, Abbas, Fausto. 小 Robbins病理學手

冊第七版 Elsevier(Singapore) Pte Ltd.．合記圖書出版社. 2008.

87. Lee LY, Hsueh S, Hsueh C. Low- grade endometrial stromal sarcoma with

metastasis to left ovary and small intestine. Annual Meeting, Taiwan Society

of Pathology, Tungs’ Taichung MetroHarbor Hospital. Nov 24, 2002. (Oral

Presentation)

88. Lee LY, Chang JT, Cheng AJ. Enhancement of radiosensitivity of

nasopharyngeal cancer cells by knockdown the expression of gp96 or GDF-15.

International Meeting on Innovative Approaches in Head and Neck Oncology.

Barcelona, February 22-24, 2006. (poster)

89. Lee LY, Kuo TT. Simultaneous occurrence of IgG4-related chronic sclerosing

dacryoadenitis and chronic sclerosing sialadenitis in a patient also with

involvement of lymph node and Warthin’s tumor. The 2nd Japanese-Taiwan

Conjoint Slide Conference. Fukuoka, Japan. September 6, 2008. (Oral

Presentation)

90. Lee LY, Ueng SH, Jung SM. A clinicopathological study of appendiceal

endometriosis in a Taiwan medical center. The 7th Asia Pacific IAP Congress

(APIAP 2011). Taipei, Taiwan. May 20-24, 2011. (poster)

Documents

＊李麗玉醫師 所有發表期刊論文 · 2015. 12. 23. · Long-term changes in trace elements in patients undergoing chronic hemodialysis. Biol Trace Elem Res. 2006;109(2):115-22

＊李麗玉醫師所有發表期刊論文 · 2015. 12. 23. · Long-term changes in trace elements in patients undergoing chronic hemodialysis. Biol Trace Elem Res. 2006;109(2):115-22